- Home
- IQV vs XYL Comparison
IQV vs XYL Comparison
Compare IQV & XYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IQV | XYL |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4B | 36.7B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | IQV | XYL |
|---|---|---|
| Price | $230.79 | $140.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $236.71 | $160.78 |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 10-28-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | N/A | ★ 13.52 |
| EPS | ★ 7.30 | 3.88 |
| Revenue | ★ $15,904,000,000.00 | $8,894,000,000.00 |
| Revenue This Year | $6.14 | $6.40 |
| Revenue Next Year | $5.28 | $4.11 |
| P/E Ratio | ★ $31.49 | $36.32 |
| Revenue Growth | 3.85 | ★ 5.58 |
| 52 Week Low | $134.65 | $100.48 |
| 52 Week High | $234.30 | $154.27 |
Technical Indicators
Market Signals| Indicator | IQV | XYL |
|---|---|---|
| Relative Strength Index (RSI) | 68.05 | 38.41 |
| Support Level | $228.69 | $137.63 |
| Resistance Level | $234.30 | $143.01 |
| Average True Range (ATR) | 5.76 | 2.65 |
| MACD | 0.89 | -0.55 |
| Stochastic Oscillator | 83.07 | 22.72 |
Price Performance
Historical ComparisonAbout IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About XYL Xylem Inc. New
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.